Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A LOW-INTERVENTIONAL LONGITUDINAL STUDY OF AN ELECTRONIC SICKLE CELL DISEASE PATIENT REPORTED OUTCOMES IN ADULT PARTICIPANTS AGED ≥18 YEARS OF AGE ON AND OFF HYDROXYUREA

NCT05407805 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT05407805
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05407805 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A LOW-INTERVENTIONAL LONGITUDINAL STUDY OF AN ELECTRONIC SICKLE CELL DISEASE PATIENT REPORTED OUTCOMES IN ADULT PARTICIPANTS AGED ≥18 YEARS OF AGE ON AND OFF HYDROXYUREA
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
February 10, 2022
Completion date
June 24, 2024
Enrollment
98 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

sickle cell disease